다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Anebulo Pharmaceuticals Inc (ANEB)
Anebulo Pharmaceuticals Inc (ANEB) 뉴스

ANEB

Anebulo Pharmaceuticals (ANEB)

Anebulo Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ANEB

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	05:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2024/05/16	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2024/05/16	02:05	Business Wire	Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2024/02/14	06:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2024/02/14	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2024/02/14	06:05	Business Wire	Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/11/22	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/11/15	06:05	Business Wire	Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/10/30	22:31	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/10/30	22:22	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/10/20	06:18	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/10/07	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/10/07	05:06	Business Wire	Anebulo Pharmaceuticals Announces New CEO	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/10/07	05:06	Business Wire	Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/10/03	06:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/09/23	05:05	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/09/21	05:29	Business Wire	Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/09/21	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/09/05	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/08/30	21:00	Business Wire	Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/08/21	21:00	Business Wire	Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/05/12	05:07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/05/11	21:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/05/11	21:00	PR Newswire (US)	Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/04/05	07:33	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/03/28	21:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/03/28	21:00	PR Newswire (US)	Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/03/08	22:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/03/08	22:00	PR Newswire (US)	Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc
2023/02/10	22:38	Business Wire	Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates	NASDAQ:ANEB	Anebulo Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:ANEB

1 2 3 4 다음 >>

Invesco BulletShares 201...

BNP Paribas Issuance

American Coastal Insurance

Supernova Partners Acqui...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관